NCT00043732View on ClinicalTrials.gov

Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

SCIO-469

All Listed Sponsors
lead

Scios, Inc.

INDUSTRY

NCT00043732 - Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate | Biotech Hunter | Biotech Hunter